AGT and Hypertension: This study aims to assess in vivo the ability of a combination of SF1 and SF3, labeled as C4, to control hypertension, vascular remodeling, inflammation, and renal and hepatic damage induced by Ang-II administration, as well as to preliminarily elucidate the mechanism of action underlying its activity against ED in vitro.